The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price gain of 17.19% this year. Over the last six months, there has been a weaker performance of 0.73%. The price of SNY fallen by 4.38% during the last 30 days period. For the last 5-days stocks have improved 5.15%.
The market performance of Sanofi ADR’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $58.97 on 09/04/24, while the lowest value for the same duration was $45.22 on 04/18/24.
52-week price history of SNY Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Sanofi ADR’s current trading price is -4.15% away from its 52-week high, while its distance from the 52-week low is 24.99%. The stock’s price range during this period has varied between$45.22 and $58.97. The Sanofi ADR’s shares, which operate in the Healthcare, saw a trading volume of around 4.31 million for the day, a figure considerably higher than their average daily volume of 2.38 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Sanofi ADR (SNY) has experienced a quarterly rise of 17.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 141.71B and boasts a workforce of 84587 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 51.27, with a change in price of +1.05. Similarly, Sanofi ADR recorded 2,329,302 in trading volume during the last 100 days, posting a change of +1.89%.
SNY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SNY stands at 0.23. Similarly, the long-term debt-to-equity ratio is also 0.17.
SNY Stock Stochastic Average
Sanofi ADR’s raw stochastic average for the past 50 days is presently 97.08%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 92.96%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 73.88% and 76.29%, respectively.
